- Home
- RZLT vs HRTX Comparison
RZLT vs HRTX Comparison
Compare RZLT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- HRTX
- Stock Information
- Founded
- RZLT 2010
- HRTX 1983
- Country
- RZLT United States
- HRTX United States
- Employees
- RZLT N/A
- HRTX N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- RZLT Health Care
- HRTX Health Care
- Exchange
- RZLT Nasdaq
- HRTX Nasdaq
- Market Cap
- RZLT 626.4M
- HRTX 206.9M
- IPO Year
- RZLT N/A
- HRTX 1987
- Fundamental
- Price
- RZLT $7.71
- HRTX $1.21
- Analyst Decision
- RZLT Strong Buy
- HRTX Strong Buy
- Analyst Count
- RZLT 4
- HRTX 2
- Target Price
- RZLT $11.67
- HRTX $4.50
- AVG Volume (30 Days)
- RZLT 921.0K
- HRTX 1.4M
- Earning Date
- RZLT 11-06-2025
- HRTX 11-11-2025
- Dividend Yield
- RZLT N/A
- HRTX N/A
- EPS Growth
- RZLT N/A
- HRTX N/A
- EPS
- RZLT N/A
- HRTX N/A
- Revenue
- RZLT N/A
- HRTX $149,694,000.00
- Revenue This Year
- RZLT N/A
- HRTX $10.62
- Revenue Next Year
- RZLT N/A
- HRTX $12.99
- P/E Ratio
- RZLT N/A
- HRTX N/A
- Revenue Growth
- RZLT N/A
- HRTX 9.78
- 52 Week Low
- RZLT $2.22
- HRTX $1.04
- 52 Week High
- RZLT $8.34
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- RZLT 64.10
- HRTX 28.21
- Support Level
- RZLT $7.23
- HRTX $1.25
- Resistance Level
- RZLT $8.34
- HRTX $1.27
- Average True Range (ATR)
- RZLT 0.36
- HRTX 0.06
- MACD
- RZLT -0.05
- HRTX 0.01
- Stochastic Oscillator
- RZLT 55.83
- HRTX 8.70
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.